Neurobiology of depression

Neuron

Volumn 34, Issue 1, 2002, Pages 13-25

  Nestler, Eric J ^a   Barrot, Michel ^a   DiLeone, Ralph J ^a   Eisch, Amelia J ^a   Gold, Stephen J ^a   Monteggia, Lisa M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOCORTICOID; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AMYGDALOID NUCLEUS; AVERSION THERAPY; BRAIN DYSFUNCTION; CIRCADIAN RHYTHM; CORTICOTROPIN RELEASE; DEPRESSION; DRUG ACTIVITY; EATING; ELECTROCONVULSIVE THERAPY; ENERGY; GENE IDENTIFICATION; GENETIC PREDISPOSITION; GENETIC RESISTANCE; HIPPOCAMPUS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOTIVATION; NEUROBIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; REVIEW; REWARD; SLEEP;

EID: 0037187646     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(02)00653-0     Document Type: Review

References (89)

1. Molecular regulation of eating behavior: New insights and prospects for therapeutic strategies
2. Mood disorders: Introduction and overview
3. Neurotrophins and depression
4. The role of corticotropin-releasing factor in depression and anxiety disorders
5. Rapid reversal of psychotic depression using mifepristone
6. Addiction, dopamine, and the molecular mechanisms of memory
7. Mood disorders: Epidemiology
8. Hippocampal volume reduction in major depression
9. Dopamine and depression
10. Basic concepts in the study of diseases with complex genetics
11. Is the amygdala a locus of "conditioned fear"? Some questions and caveats
12. Regulation of cocaine reward by CREB
13. Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect
14. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication
15. CREB is essential for the upregulation of BDNF transcription, but not the behavioral or endocine responses to antidepressant drugs
16. Are different parts of the extended amygdala involved in fear versus anxiety?
17. Stress, glucocorticoids and development
18. The concepts of the ventral striatopallidal system and extended amygdala
19. Reciprocal changes in prefrontal and limbic dopamine responsiveness to adverse and rewarding stimuli after chronic mild stress: Implications for the psychobiology of depression
20. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression
21. Neuroimaging and neuropathological studies of depression: Implications for the cognitive-emotional features of mood disorders
22. A molecular and cellular hypothesis of depression
23. Regulation of adult neurogenesis by antidepressant treatment
24. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems
25. Major depressive disorder
26. Maternal care and the development of stress responses
27. Pharmacology of antidepressants
28. Mini-review: In vivo neurogenesis in the adult brain: Regulation and functional implications
29. Modulation of brain reward circuitry by leptin
30. Behavioral effects of alpha-MSH and MCH after central administration in the female rat
31. Neuronal and neurochemical substrates of reinforcement
32. Fear memory retrieval induces CREB phosphorylation and Fos expression within the amygdala
33. The role of childhood trauma in the neurobiology of mood and anxiety disorders: Preclinical and clinical studies
34. Animal models of psychiatric disorders and their relevance to alcoholism
35. Stress, hypercortisolism and corticosteroid receptors in depression: Implications for therapy
36. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor
37. PDE4 cAMP-specific phosphodiesterases
38. Stimulation of protein kinase A activity in the rat amygdala enhances reward-related learning
39. Long-term memory is facilitated by CREB overexpression in the amygdala
40. Neurotrophins and time: Different roles for TrkB signaling in hippocampal long-term potentiation
41. Corticotropin-releasing hormine in depression and post-traumatic disorder
42. Neuroscience of addiction
43. The involvement of brain-derived neurotrophic factor in hippocampal long-term potentiation revealed by gene targeting experiments
44. CART peptides: Novel addiction- and feeding-related neuropeptides
45. Effect of chronic restraint stress and tianeptine on growth fators, growth-associated protein-43, and microtubule-associated protein 2 mRNA expression in rat hippocampus
46. Emotion circuits in the brain
47. The role of functional neuroimaging in the neuropsychology of depression
48. A prescription to resist proscription for murine models of depression
49. CRF and urocortin decreased brain stimulation reward in the rat: Reversal by a CRF receptor antagonist
50. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
51. The cellular neurobiology of depression
52. Genetic approaches to memory storage
53. Allostasis and allostatic load: Implications for neuropsychopharmacology
54. Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain
55. Molecular basis of neural plasticity underlying addiction
56. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex
57. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments
58. Chronic antidepressant administration increases the expression of CREB in rat hippocampus
59. Altered dendritic spine density in animal models of depression and in response to antidepressant treatment
60. Chronic desipramine treatment selectively potentiates somatostatin-induced dopamine release in the nucleus accumbens
61. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice
62. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated CREB expression in the nucleus accumbens
63. Animal models of depression: Utility for transgenic research
64. Hisopathology of the prefrontal cortex in major depression: What does it tell us about dysfunctional monoaminergic circuits?
65. Conditional deletion of brain-derived neurotrohpic factor in the postnatal brain leads to obesity and hyperactivity
66. The biology of affective disorders
67. Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain
68. Molecular genetics of mood disorders
69. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders
70. Multiple reward signals in the brain
71. Regional and cellular mapping of CRE-mediated transcription during naltrexone-precipitated morphine withdrawal
72. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression
73. Brain derived neurotrophic factor produces antidepressant effects in behavioral models of depression
74. cAMP and memory: A seminal lesson from Drosophila and Aplysia
75. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF)
76. Stress and glucocorticoids affect the expressing of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus
77. Stress increases brain-derived neurotrophic factor messenger ribonucleic acid in the hypothalamus and pituitary
78. Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms
79. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism
80. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment
81. Orexin-a activates phospholipase C- and protein kinase C-mediated Ca2+ signaling in dopamine neurons of the ventral tegmental area
82. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex
83. To eat or to sleep? Orexin in the regulation of feeding and wakefulness
84. Animal models of depression: Validity and applications
85. Addictive drugs and brain stimulation reward
86. Drug-activation of brain reward pathways
87. Limbic dopaminergic adaptation to a stressful stimulus in a rat model of depression
88. Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression